1. Home
  2. NSYS vs PASG Comparison

NSYS vs PASG Comparison

Compare NSYS & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nortech Systems Incorporated

NSYS

Nortech Systems Incorporated

HOLD

Current Price

$9.05

Market Cap

25.5M

Sector

Technology

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$8.66

Market Cap

28.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSYS
PASG
Founded
1981
2017
Country
United States
United States
Employees
744
27
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5M
28.3M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
NSYS
PASG
Price
$9.05
$8.66
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$34.50
AVG Volume (30 Days)
5.0K
32.2K
Earning Date
01-01-0001
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.47
EPS
N/A
N/A
Revenue
$14,371,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.01
N/A
52 Week Low
$6.50
$0.28
52 Week High
$12.40
$20.00

Technical Indicators

Market Signals
Indicator
NSYS
PASG
Relative Strength Index (RSI) 52.64 39.35
Support Level $8.86 $8.64
Resistance Level $9.82 $9.29
Average True Range (ATR) 0.45 0.97
MACD -0.08 0.06
Stochastic Oscillator 53.42 18.74

Price Performance

Historical Comparison
NSYS
PASG

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: